Could a 4-Week steroid course be safer for vasculitis patients?
NCT ID NCT06983821
First seen Jan 31, 2026 · Last updated May 17, 2026 · Updated 12 times
Summary
This study tests whether a shorter, lower-dose steroid treatment (4 weeks) combined with standard medications can safely control ANCA-associated vasculitis in people with severe kidney involvement. The goal is to reduce serious infections while still managing the disease. About 36 adults with new or relapsing vasculitis and kidney damage will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRANULOMATOSIS WITH POLYANGIITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St-Joseph's Hospital
NOT_YET_RECRUITINGHamilton, Ontario, Canada
-
The Ottawa Hospital
RECRUITINGOttawa, Ontario, Canada
Conditions
Explore the condition pages connected to this study.